3.0
Aug 11, 2011
Anonymous employee
Current employee
San Diego, CA
Recommend
CEO approval
Business Outlook
Pros
Good job security as the company is intentionally understaffed to increase margins. Compensation still a bit above market, but weighted towards equity
Cons
Stock price has little upside Sequencing is becoming more commoditized and Illumina relies on high margins which will likely dwindle over time Poor work-life balance A tremendous lack of leadership below CEO level, still acts like a $100M revenue company